This PDF is the current document as it appeared on Public Inspection on 09/04/2015 at 08:45 am.
On the basis of the record  developed in the subject five-year review, the United States International Trade Commission (“Commission”) determines, pursuant to the Tariff Act of 1930, that revocation of the antidumping duty order on chloropicrin from China would be likely to lead to continuation or recurrence of material injury to an industry in the United States within a reasonably foreseeable time.
The Commission, pursuant to section 751(c) of the Tariff Act of 1930 (19 U.S.C. 1675(c)), instituted this review on April 1, 2015 (80 FR 17496) and determined on July 6, 2015 that it would conduct an expedited review (80 FR 43461, July 22, 2015).
The Commission made this determination pursuant to section 751(c) of the Tariff Act of 1930 (19 U.S.C. 1675(c)). It completed and filed its determination in this review on August 20, 2015. The views of the Commission are contained in USITC Publication 4561 (August 2015), entitled Chloropicrin from China: Investigation No. 731-TA-130 (Fourth Review).Start Signature
By order of the Commission.
Issued: September 1, 2015.
Lisa R. Barton,
Secretary to the Commission.
[FR Doc. 2015-22061 Filed 9-4-15; 8:45 am]
BILLING CODE 7020-02-P